Related Experiment Video
Updated: May 7, 2026

Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
Mumps in Poland in 2011
Małgorzata Lipke1, Iwona Paradowska-Stankiewicz
1Department of Epidemiology, National Institute of Public Health- National Institute of Hygiene, Warsaw, Poland. mgluchowska@pzh.gov.pl
Introduction:
In 2011, similarly to previous years a decline was observed in the number of recorded cases of mumps. This favourable epidemiological situation is a result of mumps vaccination program, which from 2003 became mandatory given as two dose schemes with MMR vaccine (mumps, measles, and rubella).
Aim:
The aim of this work was to assess mumps epidemiological situation in Poland in 2011, in comparison to previous years.
Material And Methods:
The assessment of mumps epidemiological situation in Poland in 2011 was conducted by using the results of analyzed data for infectious diseases published in a yearly bulletin "Infectious diseases and poisoning in Poland in 2011" and in yearly bulletin "Preventative immunisation in Poland in 2011" Czarkowski MP and in, Warsaw, NIZP- PZH and GIS. Also used "Case definitions for infectious disease developed for epidemiological surveillance in the years 2009-2011 " (Department of Epidemiology, NIZP-PZH), as well as Preventative vaccination program 2011.
Results:
In 2011 there were 2585 reported cases of mumps. Incidence of mumps was lower 6.7/100 in comparison with 2010 (7.2/100), as well as almost twice lower than a median for the years 2005-2009. The highest incidents rate of mumps 52.0/100,000 was recorded among children at the age 5-9 years of age. Incidence in women was lower (5.6) than in men (7.9). In 2011, 24 people were hospitalized due to mumps.
Conclusion:
Systematic implementation of vaccination program against mumps as according to Inoculation Calendar has resulted in a significant decline in the number of reported cases.
Insights
Poland
Area of Science:
- Epidemiology
- Public Health
- Vaccinology
Background:
- Mumps cases declined in Poland by 2011, continuing a trend from previous years.
- This decline is attributed to the mandatory mumps vaccination program established in 2003, utilizing a two-dose MMR vaccine schedule.
- The MMR vaccine protects against mumps, measles, and rubella.
Purpose of the Study:
- To evaluate the epidemiological status of mumps in Poland during 2011.
- To compare the 2011 mumps incidence with data from preceding years.
Main Methods:
- Analysis of infectious disease data from the "Infectious diseases and poisoning in Poland in 2011" bulletin.
- Review of the "Preventative immunisation in Poland in 2011" bulletin.
- Utilized case definitions for infectious diseases (2009-2011) and the 2011 Preventative Vaccination Program.
Main Results:
- A total of 2585 mumps cases were reported in Poland in 2011.
- The incidence rate decreased to 6.7/100,000 from 7.2/100,000 in 2010, and was nearly half the 2005-2009 median.
- Children aged 5-9 years had the highest incidence rate (52.0/100,000); incidence was higher in men (7.9/100,000) than women (5.6/100,000).
- 24 individuals were hospitalized due to mumps in 2011.
Conclusions:
- Consistent adherence to the national vaccination schedule has led to a substantial reduction in reported mumps cases.
- The mumps vaccination program is effective in controlling the disease's spread.
Related Concept Videos
Infectious Diseases and Their Occurrence
Vaccinations
Influenza
Atypical Pneumonia
Viral Meningitis
Single Nucleotide Polymorphisms-SNPs

